(Q68335088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Potent V2 vasopressin antagonists with structural changes at their C-terminals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

1 January 2023

1

W. H. Sawyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

author name string

K. Bankowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

A. Misicka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

E. Nawrocka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

M. Kruszynski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

S. Stoev

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

W. A. Klis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

J. P. Przybylski

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

M. Manning

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362743

1 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3362743

1 January 2023

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0196978188900228?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

https://api.elsevier.com/content/article/PII:0196978188900228?httpAccept=text/plain

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

1 January 2023

9

1

157–63

January 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3362743

1 January 2023

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

157-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

Potent vasopressin antagonists lacking the proline residue at position 7

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

The quantitative assay of vasopressin

1 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

The Synthesis of Oxytocin1

1 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

(1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.

1 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Photoaffinity labelling of the renal V2 vasopressin receptor. Identification and enrichment of a vasopressin-binding subunit

1 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Iodinated neurohypophyseal hormones as potential ligands for receptor binding and intermediates in synthesis of tritiated hormones

1 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Solid-phase synthesis and pressor potency of [1-deamino-9-ethylenediamine]-lysine-vasopressin

1 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Novel vasopressin analogues that help define a minimum effective antagonist pharmacophore

1 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

1 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin

1 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin

1 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4

1 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4

1 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Carboxy terminus of vasopressin required for activity but not binding

1 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin

1 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors

1 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor

1 January 2023

26

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Differences in the antidiuretic responses of rats to the intravenous administration of lysine and arginine vasopressins

1 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone

1 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

pA, a new scale for the measurement of drug antagonism

1 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

Synthetic metabolites of neurohypophyseal hormones. [Des-9-glycinamide]oxytocin and [des-9-glycinamide,des-8-leucine]oxytocin

1 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0196-9781(88)90022-8

1 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3362743%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference